Home / Inspections / 1267899

FDA Inspection 1267899 — Aino Co., Ltd. of North China Pharma. Group

Aino Co., Ltd. of North China Pharma. Group — FEI 3004090057

The FDA completed an inspection of Aino Co., Ltd. of North China Pharma. Group on March 14, 2025 in Shijiazhuang, Hebei. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 14, 2025
Fiscal Year
2025
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Shijiazhuang, Hebei (China)

Facility

Other inspections at this facility

  • 1078188 (VAI Thu Jan 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 972459 (VAI Fri Apr 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 888168 (VAI Fri Jun 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 754952 (VAI Fri Nov 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 598515 (VAI Thu Jul 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources